open/close global search bar

26 July 2017

Conference talk

Chris Johns - Proton MR & CT imaging n the assessment of Pulmonary Hypertension

Key Contributors

Chris Johns University of Sheffield United Kingdom

Comments (0)

Related Content

Gérald Simonneau - Drug development in PAH: Where we started and where we are today thumbnail image

Conference talk

30 July 2019

{{GlobalController.truncateTitle("Gérald Simonneau - Drug development in PAH: Where we started and where we are today ", 65)}}
Olivier Sitbon - Recent Phase 2 trials in PAH that were unsuccessful thumbnail image

Conference talk

30 July 2019

{{GlobalController.truncateTitle("Olivier Sitbon - Recent Phase 2 trials in PAH that were unsuccessful", 65)}}
Kurt Stenmark - Relevance of animal models of pulmonary hypertension in drug development thumbnail image

Conference talk

30 July 2019

{{GlobalController.truncateTitle("Kurt Stenmark - Relevance of animal models of pulmonary hypertension in drug development", 65)}}
Sébestien Bonnet - Improving the rigour of preclinical studies to identify promising therapies thumbnail image

Conference talk

30 July 2019

{{GlobalController.truncateTitle("Sébestien Bonnet - Improving the rigour of preclinical studies to identify promising therapies", 65)}}
Krishna Prasad - What do regulators expect from phase 2 trials and adaptive designs? thumbnail image

Conference talk

30 July 2019

{{GlobalController.truncateTitle("Krishna Prasad - What do regulators expect from phase 2 trials and adaptive designs? ", 65)}}

Add to reading list

Please enter a list name.

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg